These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38732171)

  • 1. Role of Bioactives in Neurodegenerative Diseases.
    Zacharia LC
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Role of Phytochemicals.
    Velmurugan BK; Rathinasamy B; Lohanathan BP; Thiyagarajan V; Weng CF
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30262792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulatory role of non-coding RNAs and their interactions with phytochemicals in neurodegenerative diseases: a systematic review.
    Fakhri S; Darvish E; Narimani F; Moradi SZ; Abbaszadeh F; Khan H
    Brief Funct Genomics; 2023 Apr; 22(2):143-160. PubMed ID: 36722043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal attenuating therapies in neurodegenerative disease.
    Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
    Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
    Lauterbach EC; Victoroff J; Coburn KL; Shillcutt SD; Doonan SM; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):8-18. PubMed ID: 20160205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration.
    Mittal P; Goyal R; Kapoor R; Wan C; Gautam RK
    Curr Neuropharmacol; 2023; 21(4):777-786. PubMed ID: 36825704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
    Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
    CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurodegenerative disorders: the role of genetic factors in their origin and the efficiency of treatment].
    Sukhanov VA; Ionov ID; Piruzian LA
    Fiziol Cheloveka; 2005; 31(4):119-30. PubMed ID: 16122046
    [No Abstract]   [Full Text] [Related]  

  • 9. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
    Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
    Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Briffa M; Ghio S; Neuner J; Gauci AJ; Cacciottolo R; Marchal C; Caruana M; Cullin C; Vassallo N; Cauchi RJ
    Neurosci Lett; 2017 Jan; 638():12-20. PubMed ID: 27919712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential implications of polyphenolic compounds in neurodegenerative diseases.
    Shi R; Gao D; Stoika R; Liu K; Sik A; Jin M
    Crit Rev Food Sci Nutr; 2024; 64(16):5491-5514. PubMed ID: 36524397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.
    Frandsen JR; Narayanasamy P
    Redox Biol; 2018 Apr; 14():465-473. PubMed ID: 29080525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.
    Gonçalves PB; Sodero ACR; Cordeiro Y
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34065606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
    Salahuddin P; Rabbani G; Khan RH
    Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?
    Macdonald R; Barnes K; Hastings C; Mortiboys H
    Biochem Soc Trans; 2018 Aug; 46(4):891-909. PubMed ID: 30026371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.